Dr. Christopher Burcham, Eli Lilly and Company
Prof. Junbo Gong, Tianjin University
Prof. Calvin Changquan Sun, University of Minnesota
Dr. Jian Wang, CfPC/J-Star/Porton
Prof. Kevin Roberts, University of Leeds
Prof. Ken Morris, Long Island University
In light of the balancing act among quality, speed, and cost, collaborative partnering between pharmaceutical companies and contract research/manufacturing organizations is becoming increasingly important in meeting our goals of...
Problems associated with polymorphic instability and increasingly insoluble drug candidates represent white space to innovate novel forms and processing methods with better properties in the drug product. But...
